Your privacy choices

Optional analytics are off unless you choose to allow them. They help us understand public page and button usage. Essential inquiry, order and security functions remain available.

Chat messages and form contents are not marketing analytics. Read our privacy notice.

Affiliate referrals

Referral attribution is a separate choice. Allow it to recognize the affiliate who introduced you, or turn it off to stop using referral cookies.

Skip to content
Raphael Pharmaceutical
About⌄
Company overviewLeadershipMedia & PublicationsNews & Press
Science⌄
Science & PipelineResearch AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations
RaphaWell⌄
Product overviewHow to useProduct FAQAvailability
Investors⌄
Company at a GlanceStock informationSEC filingsPresentationsGovernanceInvestor Relations contact
Partner With Us⌄
Strategic partnershipsAffiliate program
ContactSign In
Explore Raphael
About⌄
Company overviewLeadershipMedia & PublicationsNews & Press
Science⌄
Science & PipelineResearch AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations
RaphaWell⌄
Product overviewHow to useProduct FAQAvailability
Investors⌄
Company at a GlanceStock informationSEC filingsPresentationsGovernanceInvestor Relations contact
Partner With Us⌄
Strategic partnershipsAffiliate program
ContactSign In
Discover RaphaWell

Raphael Pharmaceutical

SEC filings

SEC filings

A useful direct gateway to the issuer record.

Raphael does not recreate SEC filing metadata, figures or market data on this page. The authoritative issuer record remains the source for availability and reporting status.

Authoritative source

SEC EDGAR issuer record

Use the SEC issuer lookup for Raphael Pharmaceutical Inc. (CIK 1415397). Review each filing directly in EDGAR before relying on it.

Open SEC issuer record →
Public-company information

Investor Relations overview

Return to the public investor center for company context, milestones, governance, IP and source-linked updates.

Investor overview →
News & evidence

Dated source records

Company updates, study materials and publication records remain categorized and linked to their sources.

View News & Publications →
RAPHAELPHARMACEUTICAL

Science intelligence.
Greater possibilities.

Contact Raphael

About

LeadershipMedia & PublicationsNews & Press

Science

Research AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations

RaphaWell

How to useProduct FAQAvailability

Investors

Stock informationSEC filingsPresentationsGovernanceInvestor Relations contact

Partner With Us

Affiliate program

Policies

PrivacyTerms of useAffiliate termsAccessibility

© Raphael Pharmaceutical Inc.